TIMP1 and cancer: TIMP1 treatment definitely mediates anti-apoptotic activity through ligand-receptor interactions via a FAK/PI3K/AKT pathway and ERK in central nervous system (CNS) injury, inflammation, and cancer cells [33, 82, 83].